After H.C. Wainwright and Stifel Nicolaus gave Inovio Pharmaceuticals (NASDAQ: INO) a Buy rating last month, the company received another
Tag: Jason McCarthy
Analysts Offer Insights on Healthcare Companies: Biocept (NASDAQ: BIOC), Becton Dickinson (NYSE: BDX) and Aurinia Pharmaceuticals (NASDAQ: AUPH)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biocept (BIOC –
Maxim Group Assigns a Buy Rating on Cassava Sciences (SAVA)
Maxim Group analyst Jason McCarthy assigned a Buy rating to Cassava Sciences (SAVA – Research Report) today and set a
Maxim Group Reaffirms Their Buy Rating on Bellerophon (BLPH)
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Bellerophon (BLPH – Research Report),
Maxim Group Maintains Their Buy Rating on Moleculin Biotech (MBRX)
Maxim Group analyst Jason McCarthy maintained a Buy rating on Moleculin Biotech (MBRX – Research Report) today and set a
Agile Therapeutics (AGRX) Received its Third Buy in a Row
After Oppenheimer and H.C. Wainwright gave Agile Therapeutics (NASDAQ: AGRX) a Buy rating last month, the company received another Buy,
Maxim Group Keeps a Buy Rating on Soligenix (SNGX)
Maxim Group analyst Jason McCarthy maintained a Buy rating on Soligenix (SNGX – Research Report) today and set a price